Blues TEC Assessment Endorses CRT For Mild Heart Failure
This article was originally published in The Gray Sheet
Executive Summary
Using cardiac resynchronization therapy to treat patients suffering from mild heart failure is supported by existing clinical evidence. That is not the case, however, for asymptomatic patients, according to a new assessment issued by Blue Cross Blue Shield’s Technology Evaluation Center.
You may also be interested in...
More Patients Should Receive Cardiac Resynchronization Therapy, Heart Groups Say
In revised practice guidelines released Sept. 10, the American Heart Association, the Heart Rhythm Society and the American College of Cardiology Foundation say new evidence shows that many patients with mild heart failure can benefit from cardiac resynchronization devices.
News In Brief
FDA device funding flat in Senate bill
News In Brief
FDA device funding flat in Senate bill